Solid Biosciences (SLDB) Receivables - Other (2020 - 2022)

Solid Biosciences has disclosed Receivables - Other across 3 years of filings, most recently posting $14000.0 for Q1 2022.

• Receivables - Other for Q1 2022 came in at $14000.0, down 95.0% year-over-year; the trailing twelve-month figure through Mar 2022 was $14000.0 (down 95.0% YoY), and the FY2021 annual result was $110000.0, changed N/A from the prior year.
• Receivables - Other came in at $14000.0 for Q1 2022 at Solid Biosciences, down from $110000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $594000.0 in Q3 2021 to a low of $14000.0 in Q1 2022.
• The 3-year median for Receivables - Other is $283000.0 (2020), against an average of $261666.7.
• Across the five-year window, Receivables - Other changed 0.0% in 2021 and sank 95.0% in 2022, its largest moves.
• Solid Biosciences' Receivables - Other stood at $286000.0 in 2020, then slumped by 61.54% to $110000.0 in 2021, then sank by 87.27% to $14000.0 in 2022.
• The last three Receivables - Other figures came in at $14000.0 (Q1 2022), $110000.0 (Q4 2021), and $594000.0 (Q3 2021), per Business Quant data.